Abstract 4282: Morning versus Nighttime Antihypertensive Dosing and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.4282 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von vinicius parreira und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The optimal timing of antihypertensive therapy remains uncertain despite recent large randomized trials. We conducted an updated systematic review and meta-analysis to compare morning versus nighttime dosing on cardiovascular outcomes.
Methods
We systematically searched PubMed, Embase, and Web of Science for randomized controlled trials enrolling patients with hypertension assigned to morning or nighttime dosing. Pooled risk ratios (RR) with 95% confidence intervals (CI) were calculated using random-effects models, and heterogeneity was assessed using the I 2 statistic. Sensitivity analyses were performed using a leave-one-out approach.
Results
Five randomized controlled trials including 42,075 participants were analyzed. No significant differences were observed between morning and nighttime dosing for all-cause mortality (RR 0.99; 95% CI 0.91-1.08; I 2 =0%), myocardial infarction (RR 1.14; 95% CI 0.98-1.33; I 2 =0%), major adverse cardiovascular events (RR 1.04; 95% CI 0.92-1.19; I 2 =0%), or stroke (RR 0.95; 95% CI 0.75-1.20; I 2 =49.9%). Sensitivity analyses confirmed the robustness of these findings, with consistent results across leave-one-out evaluations.
Conclusions
Morning and nighttime antihypertensive dosing strategies were associated with similar cardiovascular outcomes. Dosing time was not associated with differences in major cardiovascular events and does not appear to be a key determinant of cardiovascular risk reduction.
Zitieren
APA
parreira, V., Cheidde, L., Silva, A. D., Megiolaro, M., Giffoni, B., Santos, K. D. A. D., Suruagy-Motta, R., & Harmouch, K. M. (2026). Abstract 4282: Morning versus Nighttime Antihypertensive Dosing and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.4282
Vancouver
parreira V, Cheidde L, Silva AD, Megiolaro M, Giffoni B, Santos KDAD, et al. Abstract 4282: Morning versus Nighttime Antihypertensive Dosing and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.4282
BibTeX
@article{parreira2026,
author = {parreira, vinicius and Cheidde, Lidia and Silva, Amanda Deolindo and Megiolaro, Mateus and Giffoni, Bruna and Santos, Karlos Daniell Araujo Dos and Suruagy-Motta, Ricardo and Harmouch, Khaled M.},
title = {Abstract 4282: Morning versus Nighttime Antihypertensive Dosing and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Trials},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.4282}
}
EUVIMED